247 related articles for article (PubMed ID: 12531359)
1. Tumor antigen-specific T cells and cancer immunotherapy: current issues and future prospects.
Kalos M
Vaccine; 2003 Jan; 21(7-8):781-6. PubMed ID: 12531359
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic cancer vaccines: From initial findings to prospects.
Song Q; Zhang CD; Wu XH
Immunol Lett; 2018 Apr; 196():11-21. PubMed ID: 29407608
[TBL] [Abstract][Full Text] [Related]
3. The present status and future prospects of peptide-based cancer vaccines.
Hirayama M; Nishimura Y
Int Immunol; 2016 Jul; 28(7):319-28. PubMed ID: 27235694
[TBL] [Abstract][Full Text] [Related]
4. [Immunotherapy: new insights].
Geissler M; Weth R
Praxis (Bern 1994); 2002 Dec; 91(51-52):2236-46. PubMed ID: 12564040
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in tumour antigen-specific therapy: in vivo veritas.
Mahnke YD; Speiser D; Luescher IF; Cerottini JC; Romero P
Int J Cancer; 2005 Jan; 113(2):173-8. PubMed ID: 15386403
[TBL] [Abstract][Full Text] [Related]
6. [Tumor antigen-specific cytotoxic T lymphocytes and cancer immunotherapy - review].
Liu Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Apr; 12(2):244-8. PubMed ID: 15157343
[TBL] [Abstract][Full Text] [Related]
7. Current developments in cancer vaccines and cellular immunotherapy.
Ribas A; Butterfield LH; Glaspy JA; Economou JS
J Clin Oncol; 2003 Jun; 21(12):2415-32. PubMed ID: 12805342
[TBL] [Abstract][Full Text] [Related]
8. Immune based therapies in cancer.
Krüger C; Greten TF; Korangy F
Histol Histopathol; 2007 Jun; 22(6):687-96. PubMed ID: 17357098
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy of cancer by active vaccination: does allogeneic bone marrow transplantation after non-myeloablative conditioning provide a new option?
Zöller M
Technol Cancer Res Treat; 2003 Jun; 2(3):237-60. PubMed ID: 12779354
[TBL] [Abstract][Full Text] [Related]
10. Antigen-specific immunotherapy and cancer vaccines.
Jäger E; Jäger D; Knuth A
Int J Cancer; 2003 Oct; 106(6):817-20. PubMed ID: 12918057
[TBL] [Abstract][Full Text] [Related]
11. Human Tumor Antigens and Cancer Immunotherapy.
Vigneron N
Biomed Res Int; 2015; 2015():948501. PubMed ID: 26161423
[TBL] [Abstract][Full Text] [Related]
12. Cancer vaccines. Any future?
Myc LA; Gamian A; Myc A
Arch Immunol Ther Exp (Warsz); 2011 Aug; 59(4):249-59. PubMed ID: 21644030
[TBL] [Abstract][Full Text] [Related]
13. Next generation approaches for tumor vaccination.
Patel A; Kaufman HL; Disis ML
Chin Clin Oncol; 2017 Apr; 6(2):19. PubMed ID: 28482672
[TBL] [Abstract][Full Text] [Related]
14. A novel era of cancer/testis antigen in cancer immunotherapy.
Meng X; Sun X; Liu Z; He Y
Int Immunopharmacol; 2021 Sep; 98():107889. PubMed ID: 34174699
[TBL] [Abstract][Full Text] [Related]
15. Tumor vaccine: current trends in antigen specific immunotherapy.
Baral R
Indian J Exp Biol; 2005 May; 43(5):389-406. PubMed ID: 15900903
[TBL] [Abstract][Full Text] [Related]
16. Cancer immunotherapy: moving forward with peptide T cell vaccines.
Kumai T; Fan A; Harabuchi Y; Celis E
Curr Opin Immunol; 2017 Aug; 47():57-63. PubMed ID: 28734176
[TBL] [Abstract][Full Text] [Related]
17. Whole tumor cell vaccines for glioma immunotherapy.
Field CS; Hermans IF; Hunn MK
Immunotherapy; 2016; 8(4):387-9. PubMed ID: 26973119
[No Abstract] [Full Text] [Related]
18. Current status and future perspectives of dendritic cell-based cancer immunotherapy.
H Yi D; Appel S
Scand J Immunol; 2013 Aug; 78(2):167-71. PubMed ID: 23672402
[TBL] [Abstract][Full Text] [Related]
19. Tumor-specific antigens and immunologic adjuvants in cancer immunotherapy.
Seremet T; Brasseur F; Coulie PG
Cancer J; 2011; 17(5):325-30. PubMed ID: 21952282
[TBL] [Abstract][Full Text] [Related]
20. Strategies of antigen-specific T-cell-based immunotherapy for cancer.
Liu SH; Zhang M; Zhang WG
Cancer Biother Radiopharm; 2005 Oct; 20(5):491-501. PubMed ID: 16248765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]